CN101618030B - 一种雷公藤内酯醇透皮贴剂及其制备方法 - Google Patents
一种雷公藤内酯醇透皮贴剂及其制备方法 Download PDFInfo
- Publication number
- CN101618030B CN101618030B CN2009100130273A CN200910013027A CN101618030B CN 101618030 B CN101618030 B CN 101618030B CN 2009100130273 A CN2009100130273 A CN 2009100130273A CN 200910013027 A CN200910013027 A CN 200910013027A CN 101618030 B CN101618030 B CN 101618030B
- Authority
- CN
- China
- Prior art keywords
- triptolide
- sensitive adhesive
- radix tripterygii
- tripterygii wilfordii
- pressure sensitive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn - After Issue
Links
- DFBIRQPKNDILPW-CIVMWXNOSA-N Triptolide Chemical compound O=C1OCC([C@@H]2C3)=C1CC[C@]2(C)[C@]12O[C@H]1[C@@H]1O[C@]1(C(C)C)[C@@H](O)[C@]21[C@H]3O1 DFBIRQPKNDILPW-CIVMWXNOSA-N 0.000 title claims abstract description 28
- YKUJZZHGTWVWHA-UHFFFAOYSA-N triptolide Natural products COC12CC3OC3(C(C)C)C(O)C14OC4CC5C6=C(CCC25C)C(=O)OC6 YKUJZZHGTWVWHA-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims abstract description 19
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 9
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 9
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- 150000002596 lactones Chemical class 0.000 claims description 39
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 7
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 6
- -1 siloxanes Chemical class 0.000 claims description 6
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N p-menthan-3-ol Chemical compound CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 5
- 235000010603 pastilles Nutrition 0.000 claims description 5
- 239000003655 absorption accelerator Substances 0.000 claims description 4
- 238000004026 adhesive bonding Methods 0.000 claims description 4
- 230000001464 adherent effect Effects 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 9
- 230000007794 irritation Effects 0.000 abstract description 2
- 239000003961 penetration enhancing agent Substances 0.000 abstract 1
- 239000002674 ointment Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 210000003491 skin Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 230000000149 penetrating effect Effects 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229960004756 ethanol Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 210000002683 foot Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 3
- 208000009386 Experimental Arthritis Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 229960000190 bacillus calmette–guérin vaccine Drugs 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 108010084652 homeobox protein PITX1 Proteins 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 241000545405 Tripterygium Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000293 acute skin toxicity Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000454 fifth toe Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- JNYIQRMXGCWKOU-UHFFFAOYSA-M sodium methanol chloride Chemical compound [Na+].[Cl-].OC JNYIQRMXGCWKOU-UHFFFAOYSA-M 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 231100000456 subacute toxicity Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000001226 toe joint Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100130273A CN101618030B (zh) | 2009-08-10 | 2009-08-10 | 一种雷公藤内酯醇透皮贴剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100130273A CN101618030B (zh) | 2009-08-10 | 2009-08-10 | 一种雷公藤内酯醇透皮贴剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101618030A CN101618030A (zh) | 2010-01-06 |
CN101618030B true CN101618030B (zh) | 2010-12-29 |
Family
ID=41511561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100130273A Withdrawn - After Issue CN101618030B (zh) | 2009-08-10 | 2009-08-10 | 一种雷公藤内酯醇透皮贴剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101618030B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102670565A (zh) * | 2011-03-14 | 2012-09-19 | 苏州博创园生物医药科技有限公司 | 一种含天然药物的透皮吸收贴片 |
CN102670624B (zh) * | 2011-03-14 | 2015-04-15 | 福建省医学科学研究院 | 一种治疗类风湿性关节炎的贴剂及其制备方法 |
CN109125733A (zh) * | 2018-10-30 | 2019-01-04 | 成都先手生物科技有限公司 | 一种治疗关节炎的组合物及其应用 |
CN111000888A (zh) * | 2019-12-27 | 2020-04-14 | 浙江中医药大学 | 一种雷公藤药渣贴剂及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1143318A (zh) * | 1994-01-07 | 1997-02-19 | 诺芬药品公司 | 含有作为溶解促进剂的聚乙烯吡咯烷酮的透皮装置 |
CN1705472A (zh) * | 2000-11-06 | 2005-12-07 | 株式会社三养社 | 吸水性和粘附性能改善的经皮给药*** |
-
2009
- 2009-08-10 CN CN2009100130273A patent/CN101618030B/zh not_active Withdrawn - After Issue
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1143318A (zh) * | 1994-01-07 | 1997-02-19 | 诺芬药品公司 | 含有作为溶解促进剂的聚乙烯吡咯烷酮的透皮装置 |
CN1705472A (zh) * | 2000-11-06 | 2005-12-07 | 株式会社三养社 | 吸水性和粘附性能改善的经皮给药*** |
Also Published As
Publication number | Publication date |
---|---|
CN101618030A (zh) | 2010-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101618030B (zh) | 一种雷公藤内酯醇透皮贴剂及其制备方法 | |
CN104983675B (zh) | 一种维a酸醇质体凝胶剂及其制备方法 | |
CN101455654B (zh) | 精氨酸布洛芬凝胶剂及其制备方法 | |
CN106620445A (zh) | 康肤微乳凝胶及其制备方法 | |
CN100534421C (zh) | 一种治疗抑郁症的亲水性巴布剂 | |
CN103040792B (zh) | 中药巴布剂的基质 | |
CN101991585B (zh) | 治疗类风湿性关节炎的透皮吸收涂膜剂及其制备方法 | |
KR20080063186A (ko) | 셀룰라이트 제거용 경피 조성물, 이를 포함하는 습포제 및그 제조방법 | |
CN1321655C (zh) | 一种治疗***、***炎的中药凝胶剂及其制备方法 | |
CN102423293B (zh) | 一种硝酸奥昔康唑的微乳凝胶制剂 | |
CN102085199B (zh) | 治疗类风湿性关节炎的透皮吸收生物贴剂及其制备方法 | |
CN108567782A (zh) | 一种泊沙康唑外用药物组合物、其制备方法及用途 | |
CN104367566A (zh) | 一种吲哚美辛巴布剂及其组合物 | |
CN113209007A (zh) | 积雪苷外用制剂及其制备方法 | |
CN105213677A (zh) | 一种用于表面麻醉的中药膜及其制备方法 | |
CN102670565A (zh) | 一种含天然药物的透皮吸收贴片 | |
CN103816110A (zh) | 一种促进骨折愈合的药物透皮吸收剂的制备方法 | |
CN111803469B (zh) | 一种含***透皮吸收缓释贴片及其制备方法 | |
CN102178660B (zh) | 微孔型盐酸格拉司琼透皮贴膜及其制法 | |
CN101700241A (zh) | 雷洛昔芬贴膏制剂及其制备方法 | |
CN101711754A (zh) | 枸橼酸他莫昔芬贴膏制剂及其制备方法 | |
CN102475694A (zh) | 一种用于缓解肿决及多种疼痛的外用贴剂 | |
CN101658555A (zh) | 一种风湿跌打透皮贴剂及其制备工艺 | |
CN104188895A (zh) | 甲砜霉素软膏 | |
CN100443087C (zh) | 偏诺皂苷类化合物的透皮吸收制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: KYORIN PHARMACEUTICAL CO., LTD. Owner name: KYORIN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ACTIVX BIOSCIENCES INC. Effective date: 20101027 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: CALIFORNIA STATE, UNITED STATES TO: TOKYO, JAPAN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20101105 Address after: 117000 Liaoning Benxi Economic Development Zone pharmaceutical industry base R & D Center North Applicant after: LIAONING MILLION BIOMEDICAL TECHNOLOGY Co.,Ltd. Co-applicant after: Guan Yi Address before: 110179 Liaoning province Shenyang Hunnan New Long Street No. 10-1 Applicant before: Shenyang Yiling Pharmaceutical Technology Co.,Ltd. Co-applicant before: Guan Yi |
|
C14 | Grant of patent or utility model | ||
DD01 | Delivery of document by public notice |
Addressee: Gao Dan Document name: Notification of Passing Examination on Formalities |
|
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: GUAN YI |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20110825 Address after: 117000 Liaoning Benxi Economic Development Zone pharmaceutical industry base R & D Center North Patentee after: LIAONING MILLION BIOMEDICAL TECHNOLOGY Co.,Ltd. Address before: 117000 Liaoning Benxi Economic Development Zone pharmaceutical industry base R & D Center North Co-patentee before: Guan Yi Patentee before: LIAONING MILLION BIOMEDICAL TECHNOLOGY Co.,Ltd. |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Kang Boxin Document name: Notification of Passing Examination on Formalities |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200110 Address after: 100124 1605, floor 13, building 3, No. 82, East Fourth Ring Middle Road, Chaoyang District, Beijing Patentee after: Beijing Huayao Kechuang Pharmaceutical Technology Development Co.,Ltd. Address before: 117000 Liaoning Benxi Economic Development Zone pharmaceutical industry base R & D Center North Patentee before: LIAONING MILLION BIOMEDICAL TECHNOLOGY Co.,Ltd. |
|
AV01 | Patent right actively abandoned |
Granted publication date: 20101229 Effective date of abandoning: 20230801 |
|
AV01 | Patent right actively abandoned | ||
AV01 | Patent right actively abandoned | ||
AV01 | Patent right actively abandoned |
Granted publication date: 20101229 Effective date of abandoning: 20230801 |